Eloxx Pharmaceuticals (ELOX) Acquires Zikani Therapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street dips as higher yields, rising oil prices mark shaky start to SeptemberÂ
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Eloxx Pharmaceuticals Acquires Zikani Therapeutics
April 1, 2021 7:45 AM EDTCombined Company to be Leader in Ribosomal RNA-Targeted Genetic Therapy Bringing Together Complementary Platforms
Maximizes Potential for ELX-02 for Cystic Fibrosis in Phase 2 Development
Adds Preclinical Stage Pipeline in Rare Diseases and Oncology Targeting RNAÂ and Ribosomal Mutations
Expects to File IND for First Oral Drug to Treat Patients with Recessive Dystrophic and Junctional Epidermolysis Bullosa (RDEB and JEB)
Sumit Aggarwal, Zikani President and CEO, to Lead the Combined Company
Eloxx to... More
